查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2000957

约翰氏症诊断市场：依动物种类、检测类型、通路和最终用户划分－2026-2032年全球市场预测

Johne's Disease Diagnostics Market by Animal Type, Test Type, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，约翰氏症诊断市场价值将达到 5.4216 亿美元，到 2026 年将成长至 6.1949 亿美元，到 2032 年将达到 14.5453 亿美元，年复合成长率为 15.14%。

主要市场统计数据
基准年 2025 5.4216亿美元
预计年份：2026年 6.1949亿美元
预测年份 2032 1,454,530,000 美元
复合年增长率 (%) 15.14%

约翰氏症诊断概要：重点介绍当前挑战、新兴技术和动物健康领导者的策略重点

约翰氏症已成为畜牧健康管理中持续且复杂的挑战，而准确快速的诊断是有效防治策略的关键。本文概述了当前情势，并将诊断需求置于畜群整体健康管理倡议和研究重点的背景下进行分析。此外，本文也强调了生物学、农场层面实践和检查室能力之间的相互关係，这些因素共同决定了检测结果和后续的管理策略。

分子技术的进步、整合的数据工作流程和先进的团队管理正在带来变革性的变化，重塑约翰氏症的诊断。

约翰氏症的诊断格局正在经历一场变革，这主要得益于技术创新、数据驱动的决策流程以及生产者和医疗专业人员不断变化的期望。分子扩增技术和即时检测平台缩短了检测结果的返回时间，提高了感染早期阶段的灵敏度，使得以往因诊断延迟而受限的干预措施得以实施。同时，免疫检测技术的改进提高了特异性，扩大了血清学筛检在团体管理计画中的实际应用。

分析美国关税措施对约翰氏症诊断的影响，重点在于供应链韧性、试剂进口和采购调整。

近期美国政策调整导致的关税变动对诊断产品的采购和分销趋势产生了显着影响。诊断平台、试剂和专用耗材通常在生产和分销的多个环节跨境运输。关税措施增加了进口设备和一次性试剂的到货成本，这可能会对采购预算造成压力，并延缓向下一代检测技术的升级。

透过动物种类、检测方法、最终用户、分销管道和技术对约翰氏症诊断进行细分，以帮助制定策略。

详细的细分方法阐明了诊断需求、技术需求和服务提供之间的交集，为产品开发和市场准入提供了切实可行的指南。在考虑动物种类时，检测策略需要区分牛和小反刍动物。牛的分析进一步细分为牛和牛。由于与生产相关的经济因素，乳牛牛通常需要更频繁的监测；而小反刍动物的策略则分为绵羊和山羊，它们的管理和采样方式有所不同。检测类型的细分也揭示了操作上的权衡取舍。培养方法仍然是微生物学确诊的重要手段，可在各种液体和固体培养基中进行。同时，免疫检测，例如酶联免疫吸附试验（ELISA）（有竞争性ELISA、间接ELISA和夹心ELISA等形式），提供了可扩展的筛检能力；而PCR方法，包括常规PCR和即时PCR，则可在分子水平上进行确诊并提供定量分析。

对美洲、欧洲、中东和非洲以及亚太地区的约翰氏症诊断进行区域概述：说明法规、供应和部署。

区域背景至关重要，因为不同地区的法规环境、生产系统和供应链结构差异显着。在美洲，一体化的供应链、大规模的乳牛和肉牛生产体係以及完善的实验室促进了诊断方法的应用，为高通量免疫检测和先进的分子检测创造了机会，从而支持畜群层面的监测和商业性风险管理。相较之下，欧洲、中东和非洲地区的管理体制和兽医基础设施较为分散，因此，标准协调和跨境合作对于提高可靠诊断方法的可近性以及支援区域监测活动至关重要。

企业层面的洞察，包括策略定位、伙伴关係、产品系列以及研发重点，正在塑造约翰氏症诊断领域的竞争格局。

在约翰氏症诊断领域，企业级发展趋势受到产品系列、策略伙伴关係以及对实际检验的重视等因素共同影响。主要企业正优先考虑将诊断效能与服务等级协定、培训和资料管理工具结合的整合解决方案。诊断试剂生产商、分销网络和兽医服务供应商之间的策略伙伴关係，既能扩大市场覆盖范围，又能保障品质和供应的连续性。

为产业领导者提供切实可行的建议，以加强诊断方法的采用、供应的韧性、相关人员的合作以及技术的选择。

产业领导者可以采取一系列切实可行的措施，加快约翰氏症诊断技术在其整个生产系统中的应用和有效性。首先，他们可以透过与兽医诊所、诊断检查室和农场管理者共同设计检测方法和通讯协定，使产品开发蓝图保持一致，从而确保其实用性和使用者接受度。其次，他们可以透过采购管道多元化、与区域分销商建立合作关係以及製定策略性库存管理政策来增强供应链韧性，从而减轻贸易中断和试剂短缺的影响。第三，他们可以投资于培训和技术支持，以提高现场检测的有效性，减少用户错误，并缩短与先进分子诊断相关的学习曲线。

调查方法，包括一级和二级调查方法、资料检验程序、相关人员参与和分析框架。

本次高阶主管分析的调查方法融合了定性和定量方法，以确保其严谨性和有效性。初步研究包括对实验室经理、兽医、供应链经理和科研人员进行结构化访谈，以了解实际营运、检验预期和采购决策标准。除上述相关人员外，研究也尽可能进行现场考察和流程观察，以便深入了解检体采集物流、处理能力限制和最终使用者培训需求。

整合诊断技术进步、营运挑战和策略路径，以减轻约翰氏症对整个动物健康系统的影响。

这个结论综合考虑了诊断技术的进步、营运挑战以及影响约翰氏症控制工作的策略方法。分子检测和免疫检测技术的进步为早期发现感染和实施更精细的人群干预措施提供了重要机会。然而，供应链限制、终端用户能力差异以及监管复杂性等营运障碍可能会阻碍诊断技术的进步转化为疾病影响的显着降低。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：约翰氏症诊断市场：依动物类型划分

  • 牛
    • 牛
    • 牛
  • 绵羊/山羊
    • 山羊
    • 羊

第九章：约翰氏症诊断市场－检测类型

  • 文化
    • 液体培养基
    • 固体培养基培养
  • ELISA
  • PCR
  • 基于定序的检测
    • 目标序列面板
    • 全基因组定序

第十章：约翰氏症诊断市场：依分销管道划分

  • 直销
  • 销售代理
  • 在线的

第十一章：约翰氏症诊断市场：以最终用户划分

  • 诊断检查室
    • 医院检查室
    • 独立检测实验室
  • 农场
    • 养殖场
    • 酪农
  • 研究机构
  • 动物医院

第十二章：约翰氏症诊断市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：约翰氏症诊断市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：约翰氏症诊断市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国琼氏症诊断市场

第十六章：中国约翰氏症诊断市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • HiMedia Laboratories
  • IDEXX Laboratories, Inc.
  • IDvet
  • INDICAL BIOSCIENCE GmbH
  • Merck Animal Health
  • MV Diagnostics
  • Neogen Corporation
  • PBD Biotech Ltd.
  • Pictor Diagnostics
  • Promega Corporation
  • QIAGEN NV
  • Randox Laboratories
  • Tetracore, Inc.
  • Thermo Fisher Scientific Inc.
  • VMRD, Inc.
  • Zoetis Inc.
Product Code: MRR-0D217D5AD843

The Johne's Disease Diagnostics Market was valued at USD 542.16 million in 2025 and is projected to grow to USD 619.49 million in 2026, with a CAGR of 15.14%, reaching USD 1,454.53 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 542.16 million
Estimated Year [2026] USD 619.49 million
Forecast Year [2032] USD 1,454.53 million
CAGR (%) 15.14%

Executive overview of Johne's disease diagnostics highlighting current challenges, emerging technologies, and strategic priorities for animal health leaders

Johne's disease has emerged as a persistent and complex challenge for livestock health management, with diagnostic fidelity and timeliness at the center of effective control strategies. This executive introduction sets the scene by contextualizing diagnostic needs within herd health initiatives and research priorities. It emphasizes the intersection of biology, farm-level practices, and laboratory capabilities that together determine detection outcomes and downstream management choices.

To move from recognition to action, stakeholders require clarity about diagnostic modalities, their respective performance characteristics, and how test selection interfaces with herd type and production objectives. Advances in molecular and immunological methods have introduced new opportunities, yet they coexist with legacy approaches that retain relevance depending on clinical stage and operational constraints. Consequently, diagnostic pathways must be defined with attention to animal type, specimen logistics, and the practicalities of sampling and result interpretation.

Transitioning from tactical testing to strategic surveillance demands a common framework that aligns laboratory capacity, end-user needs, and technology adoption. This introduction outlines that framework, framing diagnostic considerations as essential inputs to broader disease mitigation, biosecurity protocols, and value-chain resilience. It also underlines the need for evidence-based decision-making that harmonizes scientific rigor with the realities of field deployment and commercial animal production.

Transformative shifts reshaping Johne's disease diagnostics driven by molecular advances, integrated data workflows, and progressive herd management

The diagnostics landscape for Johne's disease is being transformed by convergence of technological innovation, data-enabled decision processes, and evolving expectations from producers and health professionals. Molecular amplification techniques and real-time detection platforms have compressed turnaround times and enhanced sensitivity in earlier stages of infection, thereby enabling interventions that were previously constrained by diagnostic latency. At the same time, improvements in immunoassay formats have refined specificity and broadened the practical utility of serological screening in herd management programs.

Concurrently, digital integration and laboratory information management systems are enabling more coherent data flows between diagnostic providers and farm operators. These integrated workflows support trend analysis, risk stratification, and targeted testing strategies that reduce unnecessary sampling while increasing the yield of diagnostically actionable information. Moreover, cross-sector collaboration between veterinary clinics, research institutions, and diagnostic laboratories is fostering validation studies and real-world evidence generation that accelerate adoption of best practices.

As these shifts take effect, operational models are also changing. On-farm sampling protocols, cold chain logistics, and remote consultation services are evolving to support broader accessibility of advanced tests. The combined effect of technological maturation and operational innovation is to make precision surveillance more attainable across production systems, provided that stakeholders address barriers related to cost, training, and regulatory harmonization.

Impact analysis of United States tariff actions on Johne's disease diagnostics, focusing on supply chain resilience, reagent imports, and procurement adjustments

Recent tariff adjustments originating from United States policy have exerted a discernible influence on the procurement and distribution dynamics of diagnostics-related goods. Diagnostic platforms, reagents, and specialty consumables commonly cross international borders during multiple stages of production and distribution. Tariff measures increase the landed cost of imported instruments and single-use reagents, which in turn exerts pressure on procurement budgets and can delay upgrades to next-generation assays.

These trade-related pressures also reverberate across supply chains, incentivizing localized sourcing but potentially limiting access to specialized reagents that remain concentrated among a limited set of global suppliers. Consequently, laboratories and clinics may face temporary capacity constraints, longer lead times, and a need to diversify suppliers. In response, many organizations are revisiting inventory policies, negotiating longer-term contracts, and evaluating kit substitution strategies to preserve continuity of diagnostic services.

Beyond immediate cost and availability effects, tariff changes have accelerated conversations about supply chain resilience and strategic sourcing. Stakeholders are increasingly evaluating alternative distribution models, regional partnerships, and localized manufacturing as mitigants. Policymakers and industry leaders should therefore consider coordinated responses that balance trade policy objectives with the operational realities of veterinary diagnostics to ensure sustained access to the tools necessary for effective disease control.

Segmentation insights for Johne's disease diagnostics across animal types, test methods, end users, distribution channels, and technologies to inform strategy

A nuanced segmentation approach clarifies where diagnostic demand, technical needs, and service delivery converge, offering actionable guidance for product development and market engagement. When considering animal type, testing strategies must differentiate between cattle and small ruminants; cattle analysis further distinguishes beef cattle and dairy cattle, with dairy herds often requiring more frequent surveillance due to production-linked economic drivers, while small ruminant strategies divide into sheep and goats with distinct management and sampling profiles. Test type segmentation likewise informs operational trade-offs: culture methods retain value for definitive microbial confirmation and are practiced in liquid media culture and solid media culture variants, whereas immunoassays such as ELISA-available in competitive ELISA, indirect ELISA, and sandwich ELISA formats-offer scalable screening capabilities, and PCR modalities including conventional PCR and real-time PCR deliver molecular confirmation and quantitative insights.

End-user segmentation underscores the differing needs and decision frameworks of diagnostic labs, farms, research institutes, and veterinary clinics. Diagnostic labs include hospital labs and independent labs, each with specific throughput and accreditation considerations; farms encompass breeding farms and dairy farms that vary in testing frequency and biosecurity practices; veterinary clinics range from independent clinics to large clinics with integrated services, while research institutes tend to focus on assay validation and longitudinal studies. Distribution channel segmentation reveals opportunities for direct sales, distributor partnerships, and online procurement, with distributors categorized as national distributors or regional distributors depending on scale and reach. Finally, technology segmentation highlights DNA-based modalities such as LAMP, PCR, and qPCR, immunoassay approaches including agar gel immunodiffusion and ELISA, and microbial culture options across liquid media and solid media platforms.

Synthesizing these segmented dimensions enables targeted product positioning and tailored commercial strategies. For instance, rapid molecular assays map well to diagnostic labs and large clinics with demand for confirmatory testing, while scalable ELISA formats align with high-volume screening needs on dairy farms and breeding operations. Understanding the interplay of animal type, test characteristics, end-user capabilities, distribution channels, and enabling technologies allows stakeholders to prioritize investments and craft differentiated value propositions.

Regional overview of Johne's disease diagnostics spanning Americas, Europe Middle East & Africa, and Asia-Pacific highlighting regulatory, supply, and adoption

Regional context matters because regulatory environments, production systems, and supply chain architectures vary substantially across geographies. In the Americas, diagnostic adoption is influenced by integrated supply chains, large-scale dairy and beef operations, and established laboratory networks, creating opportunities for high-throughput immunoassays and advanced molecular testing that support herd-level surveillance and commercial risk management. By contrast, Europe, Middle East & Africa presents a patchwork of regulatory regimes and veterinary infrastructures where harmonized standards and cross-border collaboration are key to improving access to reliable diagnostics and to supporting regional surveillance initiatives.

Asia-Pacific encompasses diverse production systems, from smallholder operations to intensive commercial farms, and has experienced rapid uptake of point-of-care and molecular testing in response to growing demand for traceability and productivity. Across all three regions, logistical considerations such as cold chain reliability, reagent import pathways, and the geographic distribution of accredited laboratories shape which diagnostic solutions are practical. Moreover, regional differences in regulatory approval timelines, lab accreditation processes, and reimbursement or subsidy frameworks influence the speed at which novel assays become operationally viable.

Taken together, regional insights suggest that successful commercial strategies must align technology deployment with local regulatory expectations, distribution realities, and end-user capabilities. Stakeholders should therefore calibrate product design, service models, and engagement approaches to the specific characteristics of the Americas, Europe Middle East & Africa, and Asia-Pacific markets to maximize uptake and operational impact.

Company-level insights into strategic positioning, partnerships, product portfolios, and R&D focus shaping the Johne's disease diagnostics competitive landscape

Company-level dynamics in Johne's disease diagnostics are shaped by the interplay of product portfolios, strategic partnerships, and an emphasis on validation under real-world conditions. Leading organizations prioritize integrated solutions that combine assay performance with service-level agreements, training, and data management tools. Strategic partnerships between diagnostic manufacturers, distribution networks, and veterinary service providers enable broader market reach while supporting quality assurance and continuity of supply.

Investment in R&D remains central to differentiation, with companies focusing on enhancing sensitivity and specificity, reducing time-to-result, and designing assays that perform robustly across specimen types and stages of infection. Meanwhile, competitive positioning often hinges on the ability to offer scalable options-from high-throughput ELISA platforms suited for herd screening to compact molecular systems designed for decentralized testing. Commercial strategies also reflect an increasing emphasis on lifecycle support, including technical training for end users, structured validation programs, and post-market performance monitoring.

Corporate initiatives that prioritize regulatory alignment, supply chain resilience, and customer-centric service offerings are more likely to achieve sustained adoption. As a result, market leaders are those that integrate technological innovation with pragmatic go-to-market models, enabling veterinary professionals and producers to convert diagnostic information into timely, actionable interventions.

Actionable recommendations for industry leaders to strengthen diagnostics adoption, supply resilience, stakeholder collaboration, and technology choices

Industry leaders can pursue a sequence of pragmatic actions to accelerate the adoption and impact of Johne's disease diagnostics across production systems. First, align product development roadmaps with end-user workflows by co-designing assays and operating protocols with veterinary clinics, diagnostic laboratories, and farm managers to ensure practical fit and user acceptance. Second, strengthen supply chain resilience through diversified sourcing, regional distributor partnerships, and strategic inventory policies that mitigate exposure to trade disruptions and reagent shortages. Third, invest in training and technical support to raise the effective performance of assays in field conditions, reduce user errors, and shorten the learning curve associated with advanced molecular methods.

Additionally, leaders should prioritize data interoperability by adopting standardized reporting formats and laboratory information systems that enable timely data sharing and trend analysis. This enhances surveillance capabilities and supports evidence-based interventions. Collaborations with research institutes can accelerate independent validation and foster real-world evidence generation that underpins broader adoption. Finally, stakeholders should engage proactively with regulatory authorities to streamline approval pathways and to clarify performance expectations for emerging diagnostics. By implementing these recommendations, organizations will improve diagnostic accessibility, enhance the quality of surveillance, and increase the overall efficacy of disease control programs.

Research methodology detailing primary and secondary research approaches, data validation procedures, stakeholder engagement, and analytical frameworks

The research methodology underpinning this executive analysis integrates qualitative and quantitative approaches to ensure rigor and relevance. Primary research comprised structured interviews with laboratory directors, veterinary practitioners, supply chain managers, and research scientists to capture operational realities, validation expectations, and procurement decision criteria. These stakeholder conversations were supplemented by site visits and process observations where feasible, allowing for a grounded appreciation of sampling logistics, throughput constraints, and end-user training needs.

Secondary research involved a systematic review of peer-reviewed literature, technical white papers, and regulatory guidance to triangulate performance claims and to contextualize technological trends. Data validation protocols were implemented to cross-check supplier specifications against independent validation studies and field performance reports. Analytical frameworks employed causal mapping and decision-tree analysis to translate technical attributes into practical implications for different end-user types and regional contexts.

Throughout, transparency in assumptions and a focus on reproducibility guided the research design. Where uncertainty exists, the methodology emphasizes evidence weighting and sensitivity analysis to distinguish well-supported findings from areas requiring further validation. This approach ensures that the insights presented are robust, actionable, and aligned with the needs of decision-makers involved in Johne's disease diagnostics.

Conclusion synthesizing diagnostic advances, operational challenges, and strategic pathways to reduce Johne's disease impact across animal health systems

This conclusion synthesizes the diagnostic advances, operational challenges, and strategic pathways that collectively shape efforts to control Johne's disease. Technological progress in molecular assays and refined immunoassays offers meaningful opportunities to detect infection earlier and to deploy more nuanced herd-level interventions. Yet, operational obstacles-such as supply chain constraints, variable end-user capacity, and regulatory complexity-can impede the translation of diagnostic improvements into measurable reductions in disease impact.

To bridge this gap, coordinated action is necessary: technology providers must align product design with the realities of end-user workflows; distribution networks should pursue resilience and responsiveness; and regulatory stakeholders must collaborate to clarify pathways that incentivize rigorous validation without imposing undue barriers. In parallel, investment in training and data infrastructure will enhance the effective use of diagnostics, enabling stakeholders to convert test results into timely management decisions.

Ultimately, the pathway to sustained improvement rests on the integration of scientific innovation with pragmatic operational planning. By prioritizing interoperability, evidence-based validation, and stakeholder collaboration, the industry can enhance the role of diagnostics in reducing disease burden and in supporting more resilient animal health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Johne's Disease Diagnostics Market, by Animal Type

  • 8.1. Cattle
    • 8.1.1. Beef Cattle
    • 8.1.2. Dairy Cattle
  • 8.2. Sheep & Goats
    • 8.2.1. Goats
    • 8.2.2. Sheep

9. Johne's Disease Diagnostics Market, by Test Type

  • 9.1. Culture
    • 9.1.1. Liquid Media Culture
    • 9.1.2. Solid Media Culture
  • 9.2. ELISA
  • 9.3. PCR
  • 9.4. Sequencing-Based Assays
    • 9.4.1. Targeted Sequencing Panels
    • 9.4.2. Whole-Genome Sequencing

10. Johne's Disease Diagnostics Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Distributors
  • 10.3. Online

11. Johne's Disease Diagnostics Market, by End User

  • 11.1. Diagnostic Labs
    • 11.1.1. Hospital Labs
    • 11.1.2. Independent Labs
  • 11.2. Farms
    • 11.2.1. Breeding Farms
    • 11.2.2. Dairy Farms
  • 11.3. Research Institutes
  • 11.4. Veterinary Clinics

12. Johne's Disease Diagnostics Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Johne's Disease Diagnostics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Johne's Disease Diagnostics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Johne's Disease Diagnostics Market

16. China Johne's Disease Diagnostics Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Bio-Rad Laboratories, Inc.
  • 17.6. bioMerieux SA
  • 17.7. HiMedia Laboratories
  • 17.8. IDEXX Laboratories, Inc.
  • 17.9. IDvet
  • 17.10. INDICAL BIOSCIENCE GmbH
  • 17.11. Merck Animal Health
  • 17.12. MV Diagnostics
  • 17.13. Neogen Corporation
  • 17.14. PBD Biotech Ltd.
  • 17.15. Pictor Diagnostics
  • 17.16. Promega Corporation
  • 17.17. QIAGEN N.V.
  • 17.18. Randox Laboratories
  • 17.19. Tetracore, Inc.
  • 17.20. Thermo Fisher Scientific Inc.
  • 17.21. VMRD, Inc.
  • 17.22. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BEEF CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY LIQUID MEDIA CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SOLID MEDIA CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING PANELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING PANELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING PANELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY WHOLE-GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY BREEDING FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DAIRY FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 192. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 225. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 227. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 235. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 236. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 242. NATO JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CATTLE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SHEEP & GOATS, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY CULTURE, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY SEQUENCING-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABS, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA JOHNE'S DISEASE DIAGNOSTICS MARKET SIZE, BY FARMS, 2018-2032 (USD MILLION)